scispace - formally typeset
K

Kai Wei Lee

Researcher at Universiti Putra Malaysia

Publications -  51
Citations -  686

Kai Wei Lee is an academic researcher from Universiti Putra Malaysia. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 8, co-authored 26 publications receiving 281 citations. Previous affiliations of Kai Wei Lee include Universiti Tunku Abdul Rahman.

Papers
More filters
Journal ArticleDOI

Prevalence and risk factors of gestational diabetes mellitus in Asia: a systematic review and meta-analysis

TL;DR: Wang et al. as mentioned in this paper conducted a systematic review and meta-analysis to determine the prevalence of Gestational Diabetes mellitus (GDM) in Asia via a systematic analysis.
ReportDOI

Psychological distress among healthcare providers during COVID-19 in Asia: Systematic review and meta-analysis.

TL;DR: In this paper, the authors performed a literature search using 4 databases from Medline, Cinahl, PubMed and Scopus from inception up to March 15, 2021 and selected relevant cross-sectional studies.
Journal ArticleDOI

Effects of Vegetarian Diets on Blood Pressure Lowering: A Systematic Review with Meta-Analysis and Trial Sequential Analysis.

TL;DR: In conclusion, vegetarian diets are associated with significant reductions in BP compared with omnivorous diets, suggesting that they may play a key role in the primary prevention and overall management of hypertension.
Journal ArticleDOI

Prevalence and factors associated with depressive, anxiety and stress symptoms among women with gestational diabetes mellitus in tertiary care centres in Malaysia: a cross-sectional study

TL;DR: Within a population of women with GDM in Malaysia, those at higher risk of having depressive, anxiety and stress symptoms can be identified from several baseline clinical characteristics.
Journal ArticleDOI

COVID-19 in People Living with HIV: A Systematic Review and Meta-Analysis.

TL;DR: In this paper, the authors focused on determining the epidemiological characteristics, clinical signs and symptoms, blood parameters, and clinical outcomes among PLHIV who contracted COVID-19.